Medtech stocks ticked down over the course of last week as the COVID-19 pandemic continues to bear economic ramifications. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — sat at 82.4 points at the end of last week (May 15). That total represents a -1.9% decline from the 83.98-point […]
Titan Medical Inc.
Titan Medical posts Q1 bottom-line gain
Titan Medical (TSX:TMD;OTC:TITFX) shares dipped today on first-quarter financial results that revealed a significant bottom-line resurgence. The Toronto-based surgical robotic technology developer posted losses of $768,043, or -2¢ per share for the three months ended March 31, 2020, for a 97.3% bottom-line gain from losses of nearly $28.3 million in the first quarter last year. Titan […]
Titan Medical may put itself up for sale
Titan Medical (TSX:TMD) CEO David McNally told shareholders today that the company must raise $85 million to finish developing its Sport robot-assisted surgery device and file for FDA clearance. The Toronto-based medical device company is considering raising that money through equity or debt, licensing, merger or acquisition. Titan Medical lost nearly half its value in October […]
Titan Medical prices offering for up to $25m for Sport robot-assisted surgery device
Titan Medical (TSX:TMD;OTC:TITFX) today priced an offering it hopes will bring in as much as $25 million, cash it desperately needs to resume development of its Sport robot-assisted surgery device. Earlier this month, shares in the Toronto-based company lost nearly half their value when Titan suspended the timeline on the Sport single-port surgery platform. The company […]
Titan Medical plunges on suspended timeline for Sport surgical robot
Titan Medical (TSX:TMD) shares lost nearly half their value this morning after the medical device company suspended the timeline for its Sport robot-assisted surgery device. Earlier this year the Toronto-based company pushed back the timeline for its 501(K) submission to the FDA from late this year to the first half of 2020. But late yesterday Titan […]
Titan Medical preps for up to $22m from overnight offering
Titan Medical (TSX:TMD;OTC:TITFX) yesterday registered an overnight offering it hopes will bring in as much as $22 million for the robot-assisted surgery platform it’s developing. Toronto-based Titan said the offering, which aims to raise a minimum of $18 million, will combine one share of stock and a single warrant; no prices have been set yet. The […]
Titan Medical inks $35m financing deal with Aspire Capital
Titan Medical (TSX:TMD;OTC:TITFX) said yesterday that it inked a share purchase agreement with Aspire Capital worth up to $35 million. In the deal, Aspire Capital committed to purchase Titan stock up to the $35 million mark until Feb. 28, 2022, at Titan’s request. Titan plans to immediately sell Aspire Capital nearly 1.8 million shares at $1.69 […]
Titan Medical delays timeline on Sport robot-assisted surgery device
Titan Medical (TSX:TMD;OTC:TITFX) today pushed back the timeline on its Sport robot-assisted surgery device, saying it now expects to file for 510(k) clearance from the FDA next year, sending its share prices down in New York and Toronto. With a successful human factors evaluation of the single-port device under its belt, the Toronto-based company said […]
Titan Medical on track for FDA, CE Mark bids this year
Titan Medical (TSX:TMD;OTC:TITFX) said today that it’s on track to submit approval bids this year for its Sport robot-assisted surgery device in the U.S. and Europe. The Toronto-based company said it completed all procedures under Good Laboratory Practices guidelines for acute and chronic animal and human cadaver studies, with slated to follow by the end of […]
Ablative Solutions taps medtech vet Rumrill for CEO | Personnel Moves, July 16, 2019
Ablative Solutions tapped 30-year industry veteran Kate Rumrill, the former chief executive at NeoSync, to be its new president & CEO. Rumrill, whose resume includes stints at Covidien, Aspect Medical Systems and Eli Lilly, is slated to keep her seat on NeoSync’s board, San Jose, Calif.-based Ablative Solutions said. The company makes the Peregine renal […]
Titan Medical shares drop slightly on Q1 earnings release
Shares in Titan Medical (NSDQ:TMDI) are down slightly today after the robotic surgical platform maker posted first quarter earnings. The Toronto-based company reported research and development expenses of approximately $14.4 million, up 340.1% from the approximate $3.3 million it reported during the first quarter of 2018. Titan Medical posted net and comprehensive loss of approximately $28.3 […]
